Liu Zhuo, Li Xiao, Ma Jie, Li Dechuan, Ju Haixing, Liu Yong, Chen Yinbo, He Xujun, Zhu Yuping
Department of Colorectal Cancer, Institute of Cancer Research & Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Zhejiang 310022, People's Republic of China.
The 2nd Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou 310053, People's Republic of China.
Onco Targets Ther. 2020 Aug 20;13:8299-8311. doi: 10.2147/OTT.S257729. eCollection 2020.
Colon cancer (CRC) is a common type of tumour, and IQGAP family proteins play an important role in many tumours. However, their roles in CRC remain unclear.
First, we searched many public databases to comprehensively analyze expression of IQGAPs in CRC. Next, real-time PCR, immunohistochemical (IHC), transwell, siRNA transfection and Western blot assays were used to evaluate relationships among IQGAP3 expression, clinical pathological parameters and CRC prognosis, and the underlying molecular mechanism was investigated.
IQGAP3 was elevated in CRC tissues, whereas there was no significant change in expression of IQGAP1 or IQGAP2. Additionally, IQGAP3 expression in CRC tissues was associated with tumour progression, invasion and poor prognosis. In mechanistic studies, we found that IQGAP3 was positively coexpressed with PIK3C2B. In an in vitro assay, the PIK3C2B expression level was increased after exogenous overexpression of IQGAP3, resulting in the promotion of cell invasion, which was blocked by pretransfecting cells with PIK3C2B siRNA. Furthermore, we found that high expression of IQGAP3 and PIK3C2B correlated with tumour stage and vessel invasion in human CRC, whereby patients with high expression of both in tumours had a worse prognosis compared with patients with single-positive or double-negative tumours.
The results of our current study and corresponding previous studies provide evidence that IQGAP3 is elevated in CRC and promotes colon cancer growth and metastasis by regulating PIK3C2B activation.
结肠癌(CRC)是一种常见的肿瘤类型,IQGAP家族蛋白在许多肿瘤中发挥重要作用。然而,它们在CRC中的作用仍不清楚。
首先,我们搜索了许多公共数据库,以全面分析IQGAPs在CRC中的表达。接下来,使用实时PCR、免疫组织化学(IHC)、Transwell、siRNA转染和蛋白质印迹分析来评估IQGAP3表达、临床病理参数与CRC预后之间的关系,并研究潜在的分子机制。
IQGAP3在CRC组织中升高,而IQGAP1或IQGAP2的表达没有显著变化。此外,CRC组织中IQGAP3的表达与肿瘤进展、侵袭和不良预后相关。在机制研究中,我们发现IQGAP3与PIK3C2B呈正共表达。在体外试验中,IQGAP3外源性过表达后PIK3C2B表达水平升高,导致细胞侵袭增加,而用PIK3C2B siRNA预转染细胞可阻断这种增加。此外,我们发现IQGAP3和PIK3C2B的高表达与人类CRC的肿瘤分期和血管侵袭相关,因此肿瘤中两者均高表达的患者与单阳性或双阴性肿瘤患者相比预后更差。
我们目前的研究结果及之前相应的研究提供了证据,表明IQGAP3在CRC中升高,并通过调节PIK3C2B的激活促进结肠癌的生长和转移。